000			01932 a2200529 4500
005			20250511205859.0
264		0	_c19920107
008			199201s 0 0 eng d
022			_a0936-3076
024	7		_a10.1007/BF02259538 _2doi
040			_aNLM _beng _cNLM
100	1		_aLöschmann, P A
245	0	0	_aSynergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease. _h[electronic resource]
260			_bJournal of neural transmission. Parkinson's disease and dementia section _c1991
300			_a203-13 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine _xpharmacology
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimals
650	0	4	_aCallithrix
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Synergism
650	0	4	_aIbotenic Acid _xanalogs & derivatives
650	0	4	_aLevodopa _xpharmacology
650	0	4	_aMale
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aOxidopamine _xpharmacology
650	0	4	_aParkinson Disease, Secondary _xdrug therapy
650	0	4	_aPiperazines _xpharmacology
650	0	4	_aQuinoxalines _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Inbred Strains
650	0	4	_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors
650	0	4	_aSubstantia Nigra _xdrug effects
650	0	4	_aalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
700	1		_aLange, K W
700	1		_aKunow, M
700	1		_aRettig, K J
700	1		_aJähnig, P
700	1		_aHonoré, T
700	1		_aTurski, L
700	1		_aWachtel, H
700	1		_aJenner, P
700	1		_aMarsden, C D
773	0		_tJournal of neural transmission. Parkinson's disease and dementia section _gvol. 3 _gno. 3 _gp. 203-13
856	4	0	_uhttps://doi.org/10.1007/BF02259538 _zAvailable from publisher's website
999			_c1841787 _d1841787